Browse stocks · Browse sectors · Healthcare · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

NSE RESEARCH WORKSPACE

Marksans Pharma Ltd

NSE: MARKSANS

OverviewFinancial StatementsQuant ScoreForensic Accounting+

Price1Y

Company Overview

Marksans Pharma Ltd is classified in Pharmaceuticals.

Market Cap: ₹ 13,001.27 Cr.
Price in snapshot: ₹ 286.9
ROE: 15.3 %
ROCE: 16.31 %
Dividend Yield: 0.32 %

Snapshot updated 22 July 2026. Figures are not live quotes.

Research coverage

Concall documents: transcript for Q1 FY27, dated 20 August 2026.
Annual-report coverage: FY2026.
Company exchange-filing catalog coverage.

Browse concall documents · Browse exchange filings